May 12 |
Here's What Analysts Are Forecasting For Royalty Pharma plc (NASDAQ:RPRX) After Its First-Quarter Results
|
May 11 |
Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend
|
May 11 |
Royalty Pharma: Solid Start Of The Year, Buy Confirmed
|
May 9 |
Royalty Pharma PLC (RPRX) Q1 2024 Earnings Call Transcript
|
May 9 |
Royalty Pharma reports Q1 results
|
May 9 |
Royalty Pharma Reports First Quarter 2024 Results
|
May 9 |
Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
|
May 8 |
Royalty Pharma Q1 2024 Earnings Preview
|
May 8 |
Teva, Medincell succeed in late-stage trial for injectable schizophrenia therapy
|
May 4 |
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21
|